Your browser doesn't support javascript.
loading
Final results of the TANIA randomised phase III trial of bevacizumab after progression on first-line bevacizumab therapy for HER2-negative locally recurrent/metastatic breast cancer.
Vrdoljak, E; Marschner, N; Zielinski, C; Gligorov, J; Cortes, J; Puglisi, F; Aapro, M; Fallowfield, L; Fontana, A; Inbar, M; Kahan, Z; Welt, A; Lévy, C; Brain, E; Pivot, X; Putzu, C; González Martín, A; de Ducla, S; Easton, V; von Minckwitz, G.
Affiliation
  • Vrdoljak E; Department of Oncology, University Hospital Split, Split, Croatia edo.vrdoljak@gmail.com.
  • Marschner N; Outpatient Cancer Center, Freiburg, Germany.
  • Zielinski C; Comprehensive Cancer Center, Medical University Vienna, Vienna, Austria.
  • Gligorov J; Central European Cooperative Oncology Group (CECOG).
  • Cortes J; Assistance Publique Hôpitaux de Paris-Tenon, IUC-UPMC, Sorbonne University, Paris, France.
  • Puglisi F; Ramon y Cajal University Hospital, Madrid.
  • Aapro M; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Fallowfield L; Department of Medical and Biological Sciences, University of Udine, Udine.
  • Fontana A; Department of Oncology, University Hospital of Udine, Udine, Italy.
  • Inbar M; Multidisciplinary Institute of Oncology, Clinique de Genolier, Genolier, Switzerland.
  • Kahan Z; Sussex Health Outcomes Research and Education in Cancer (SHORE-C), Brighton and Sussex Medical School, University of Sussex, Falmer, UK.
  • Welt A; Medical Oncology Unit 2, Pisa Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy.
  • Lévy C; Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • Brain E; Department of Oncotherapy, University of Szeged, Szeged, Hungary.
  • Pivot X; West German Cancer Center, University Duisburg-Essen, Essen.
  • Putzu C; German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany.
  • González Martín A; Oncology Department, Centre François Baclesse, Caen.
  • de Ducla S; Institut Curie-Hôpital René Huguenin, Saint-Cloud.
  • Easton V; Oncology Department, Jean Minjoz University Hospital, Besançon, France.
  • von Minckwitz G; Oncology Unit, University Hospital of Sassari, Sassari, Italy.
Ann Oncol ; 27(11): 2046-2052, 2016 11.
Article in En | MEDLINE | ID: mdl-27502725
Subject(s)
Key words
Search on Google
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antibodies, Monoclonal, Humanized / Bevacizumab / Neoplasm Recurrence, Local Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2016 Type: Article Affiliation country: Croatia
Search on Google
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antibodies, Monoclonal, Humanized / Bevacizumab / Neoplasm Recurrence, Local Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2016 Type: Article Affiliation country: Croatia